FAMPYRA fampridine 10mg modified release tablets bottle Australia - English - Department of Health (Therapeutic Goods Administration)

fampyra fampridine 10mg modified release tablets bottle

biogen australia pty ltd - fampridine, quantity: 10 mg - tablet, modified release - excipient ingredients: colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; hypromellose; titanium dioxide; macrogol 400 - fampyra modified release tablets are indicated for the symptomatic improvement of walking ability in adult patients with multiple sclerosis who have shown improvement after 8 weeks of treatment

ZETIN acitretin 10mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

zetin acitretin 10mg capsule blister pack

douglas pharmaceuticals australia pty ltd - acitretin, quantity: 10 mg - capsule, hard - excipient ingredients: titanium dioxide; purified water; sodium lauryl sulfate; iron oxide red; gelatin; maltodextrin; microcrystalline cellulose; sodium ascorbate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - acitretin may be used for the treatment of:,? severe intractable psoriasis in all its forms,? severe forms of disorders of keratinisation such as,- hyperkeratosis palmaris et plantaris,- pustulosis palmaris et plantaris,- ichthyosis,- keratosis follicularis (darier's disease),- lichen planus affecting the skin or the mucosae,- pityriasis rubra pilaris

Kenacort A10 10mg/1mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

kenacort a10 10mg/1ml injection ampoule

aspen pharma pty ltd - triamcinolone acetonide, quantity: 10 mg/ml - injection, suspension - excipient ingredients: carmellose sodium; polysorbate 80; benzyl alcohol; sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - intra-articular: kenacort-a 10 injection (sterile triamcinolone acetonide suspension usp) is indicated for intra-articular or intrasynovial administration, and for injections into tendon sheaths, as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: synovitis of osteoarthritis, rheumatoid arthritis, acute and subacute bursitis, acute gouty arthritis, epicondylitis, acute non-specific tenosynovitis, post-traumatic osteoarthritis. intradermal: intralesional administration of kenacort-a 10 injection is indicated for the treatment of keloids, discoid lupus erythermatous, necrobiosis lipoidica diabeticorum, alopecia areata and localised hypertrophic, infiltrated, inflammatory lesions of: lichen planus, psoriatic plaques, granuloma annulare, and lichen simplex chronicus ( neurodermatitis), kenacort-a 10 injection also may be useful in cystic tumours of an aponeurosis or tendon ( ganglia).

APO-Adefovir adefovir dipivoxil 10mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-adefovir adefovir dipivoxil 10mg tablet bottle

arrotex pharmaceuticals pty ltd - adefovir dipivoxil, quantity: 10 mg - tablet - excipient ingredients: pregelatinised maize starch; magnesium stearate; purified talc; croscarmellose sodium; lactose monohydrate - ? adefovir dipivoxil is indicated for the treatment of chronic hepatitis b in patients 12 years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (alt or ast) or histologically active disease. ? for adult patients, this indication is based on histological, virological, biochemical, and serological responses in adult patients with hbeag+ and hbeag-/hbvdna+ chronic hepatitis b with compensated liver function, and in adult patients with clinical evidence of lamivudine-resistant hepatitis b virus with either compensated or decompensated liver function. ? for adolescent patients (12 to <18 years of age), the indication is based on virological and biochemical responses in patients with hbeag+ chronic hepatitis b virus with compensated liver function.

ANASTROL anastrozole 1mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

anastrol anastrozole 1mg tablet blister pack

teva pharma australia pty ltd - anastrozole, quantity: 1 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; titanium dioxide; macrogol 6000; hypromellose; macrogol 400; magnesium stearate; povidone; lactose monohydrate - early breast cancer adjuvant treatment of early breast cancer in postmenopausal women with oestrogen/progesterone-receptor-positive disease. advanced breast cancer first line treatment of advanced breast cancer in postmenopausal women with oestrogen/progesterone-receptor-positive disease. treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. patients with oestrogen-receptor-negative disease and patients who have not responded to previous tamoxifen therapy rarely respond to anastrozole.

Amatib 800 mg/g oral powder for pigs and chickens Ireland - English - HPRA (Health Products Regulatory Authority)

amatib 800 mg/g oral powder for pigs and chickens

krka, d.d., novo mesto - amoxicillin trihydrate - powder for use in drinking water - 800 milligram(s)/gram - amoxicillin - chickens, pigs - antibacterial

Anthelmin Plus Flavour Tablets for dogs Ireland - English - HPRA (Health Products Regulatory Authority)

anthelmin plus flavour tablets for dogs

krka, d.d., novo mesto - febantel; pyrantel embonate ; praziquantel - tablet - 150, 144, 50 mg/tablet - febantel, combinations - dogs - endoparasiticide

Anthelmin Plus XL Tablets for dogs Ireland - English - HPRA (Health Products Regulatory Authority)

anthelmin plus xl tablets for dogs

krka, d.d., novo mesto - febantel; pyrantel embonate ; praziquantel - tablet - 525, 504, 175 mg/tablet - febantel, combinations - dogs - endoparasiticide